JPWO2022014680A1 - - Google Patents

Info

Publication number
JPWO2022014680A1
JPWO2022014680A1 JP2022536446A JP2022536446A JPWO2022014680A1 JP WO2022014680 A1 JPWO2022014680 A1 JP WO2022014680A1 JP 2022536446 A JP2022536446 A JP 2022536446A JP 2022536446 A JP2022536446 A JP 2022536446A JP WO2022014680 A1 JPWO2022014680 A1 JP WO2022014680A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022536446A
Other languages
Japanese (ja)
Other versions
JP7190612B2 (ja
JPWO2022014680A5 (cg-RX-API-DMAC10.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022014680A1 publication Critical patent/JPWO2022014680A1/ja
Application granted granted Critical
Publication of JP7190612B2 publication Critical patent/JP7190612B2/ja
Publication of JPWO2022014680A5 publication Critical patent/JPWO2022014680A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pain & Pain Management (AREA)
JP2022536446A 2020-07-17 2021-07-15 置換ピペリジン化合物及びその用途 Active JP7190612B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020122864 2020-07-17
JP2020122864 2020-07-17
PCT/JP2021/026649 WO2022014680A1 (ja) 2020-07-17 2021-07-15 置換ピペリジン化合物及びその用途

Publications (3)

Publication Number Publication Date
JPWO2022014680A1 true JPWO2022014680A1 (cg-RX-API-DMAC10.html) 2022-01-20
JP7190612B2 JP7190612B2 (ja) 2022-12-15
JPWO2022014680A5 JPWO2022014680A5 (cg-RX-API-DMAC10.html) 2022-12-16

Family

ID=79291962

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022536446A Active JP7190612B2 (ja) 2020-07-17 2021-07-15 置換ピペリジン化合物及びその用途

Country Status (32)

Country Link
US (1) US11479552B2 (cg-RX-API-DMAC10.html)
EP (1) EP4151277B1 (cg-RX-API-DMAC10.html)
JP (1) JP7190612B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230040953A (cg-RX-API-DMAC10.html)
CN (3) CN119235864A (cg-RX-API-DMAC10.html)
AR (1) AR122973A1 (cg-RX-API-DMAC10.html)
AU (1) AU2021308053A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022026161A2 (cg-RX-API-DMAC10.html)
CA (1) CA3187835A1 (cg-RX-API-DMAC10.html)
CL (1) CL2022003666A1 (cg-RX-API-DMAC10.html)
CO (1) CO2022018446A2 (cg-RX-API-DMAC10.html)
DK (1) DK4151277T3 (cg-RX-API-DMAC10.html)
ES (1) ES3067008T3 (cg-RX-API-DMAC10.html)
FI (1) FI4151277T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20260428T1 (cg-RX-API-DMAC10.html)
IL (1) IL299125B2 (cg-RX-API-DMAC10.html)
JO (1) JOP20220345A1 (cg-RX-API-DMAC10.html)
LT (1) LT4151277T (cg-RX-API-DMAC10.html)
MA (1) MA59554B1 (cg-RX-API-DMAC10.html)
MD (1) MD4151277T2 (cg-RX-API-DMAC10.html)
MX (1) MX2022016388A (cg-RX-API-DMAC10.html)
PE (1) PE20231103A1 (cg-RX-API-DMAC10.html)
PH (1) PH12022553488A1 (cg-RX-API-DMAC10.html)
PL (1) PL4151277T3 (cg-RX-API-DMAC10.html)
PT (1) PT4151277T (cg-RX-API-DMAC10.html)
RS (1) RS67943B1 (cg-RX-API-DMAC10.html)
SI (1) SI4151277T1 (cg-RX-API-DMAC10.html)
SM (1) SMT202600159T1 (cg-RX-API-DMAC10.html)
TW (2) TWI888599B (cg-RX-API-DMAC10.html)
UA (1) UA129636C2 (cg-RX-API-DMAC10.html)
WO (1) WO2022014680A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA202213562B (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20260083444A (ko) 2019-11-25 2026-06-05 알케르메스,인코포레이티드 치환된 마크로사이클릭 화합물 및 관련 치료 방법
US11760747B2 (en) 2020-12-21 2023-09-19 Alkermes, Inc. Substituted piperidino compounds and related methods of treatment
US12006330B2 (en) 2020-12-21 2024-06-11 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment
JP7833486B2 (ja) 2021-05-26 2026-03-19 アルカーメス,インコーポレイテッド 置換されるカルバメート大環状化合物および関連のある治療方法
JP7591592B2 (ja) * 2022-01-14 2024-11-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 置換ピペリジン化合物を含有する医薬
WO2023136279A1 (ja) * 2022-01-14 2023-07-20 エーザイ・アール・アンド・ディー・マネジメント株式会社 置換ピペリジン化合物の結晶並びに置換ピペリジン化合物の塩及びそれらの結晶
EP4600242A1 (en) * 2022-10-07 2025-08-13 Kissei Pharmaceutical Co., Ltd. Cyclopentane compound
TW202432109A (zh) * 2022-10-31 2024-08-16 日商武田藥品工業股份有限公司 食慾素2型受體促效劑之給藥
JPWO2024128305A1 (cg-RX-API-DMAC10.html) 2022-12-16 2024-06-20
TW202502342A (zh) 2023-06-02 2025-01-16 日商武田藥品工業股份有限公司 食慾素2受體促效劑用於改善睡眠期間之呼吸功能的用途
CN122374291A (zh) 2023-12-12 2026-07-10 爱杜西亚药品有限公司 作为食欲素受体调节剂的芳基砜及砜酮衍生物
WO2025132542A1 (en) 2023-12-19 2025-06-26 Idorsia Pharmaceuticals Ltd Macrocyclic orexin agonists
WO2025137359A1 (en) 2023-12-20 2025-06-26 Eisai R&D Management Co., Ltd. Assay methods to identify a disease
WO2025229493A1 (en) 2024-04-29 2025-11-06 Takeda Pharmaceutical Company Limited Dosing of orexin type 2 receptor agonists

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005028438A1 (ja) * 2003-09-22 2005-03-31 Banyu Pharmaceutical Co., Ltd. 新規ピペリジン誘導体
JP2008517032A (ja) * 2004-10-20 2008-05-22 ノイロサーチ アクティーゼルスカブ 新規なジアザ二環式アリール誘導体及びその医薬用途
JP2016512536A (ja) * 2013-03-13 2016-04-28 ヤンセン ファーマシューティカ エヌ.ベー. 置換した7−アザビシクル及びオレキシン受容体調節因子としてのそれらの使用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG34208A1 (en) 1995-03-01 1996-12-06 Guy Andrew Vaz Blast and fragment resistant polyurethane boot sole for safety footwear
EP0828751A4 (en) 1995-05-05 1999-01-20 Human Genome Sciences Inc HUMAN NEUROPEPTIDE RECEPTOR
US6309854B1 (en) 1996-12-17 2001-10-30 Smithkline Beecham Corporation Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
US6159605A (en) 1997-02-18 2000-12-12 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Ink-jet recording sheet
US5935814A (en) 1997-04-30 1999-08-10 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72Y receptor
US6020157A (en) 1997-04-30 2000-02-01 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72X receptor
US6166193A (en) 1997-07-25 2000-12-26 Board Of Regents, University Of Texas System Polynucleotides encoding MY1 receptor
KR100327888B1 (ko) 1999-07-14 2002-03-09 정숭렬 도로포장 파손촉진 시험장치의 무선제어 시스템
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005028438A1 (ja) * 2003-09-22 2005-03-31 Banyu Pharmaceutical Co., Ltd. 新規ピペリジン誘導体
JP2008517032A (ja) * 2004-10-20 2008-05-22 ノイロサーチ アクティーゼルスカブ 新規なジアザ二環式アリール誘導体及びその医薬用途
JP2016512536A (ja) * 2013-03-13 2016-04-28 ヤンセン ファーマシューティカ エヌ.ベー. 置換した7−アザビシクル及びオレキシン受容体調節因子としてのそれらの使用

Also Published As

Publication number Publication date
LT4151277T (lt) 2026-04-10
CN115884971A (zh) 2023-03-31
UA129636C2 (uk) 2025-06-18
BR112022026161A2 (pt) 2023-01-31
IL299125A (en) 2023-02-01
ZA202213562B (en) 2023-10-25
MX2022016388A (es) 2023-01-30
JP7190612B2 (ja) 2022-12-15
MA59554B1 (fr) 2026-04-30
CO2022018446A2 (es) 2023-03-07
IL299125B2 (en) 2026-03-01
ES3067008T3 (en) 2026-05-19
CL2022003666A1 (es) 2023-05-26
WO2022014680A1 (ja) 2022-01-20
EP4151277B1 (en) 2026-01-28
PH12022553488A1 (en) 2024-04-22
SMT202600159T1 (it) 2026-05-12
CN115884971B (zh) 2024-11-05
DK4151277T3 (da) 2026-04-13
JOP20220345A1 (ar) 2022-12-21
TWI922338B (zh) 2026-04-11
AU2021308053A1 (en) 2023-02-02
SI4151277T1 (sl) 2026-05-29
MD4151277T2 (ro) 2026-05-31
IL299125B1 (en) 2025-11-01
FI4151277T3 (fi) 2026-03-27
TWI888599B (zh) 2025-07-01
TW202216705A (zh) 2022-05-01
HRP20260428T1 (hr) 2026-05-08
US11479552B2 (en) 2022-10-25
KR20230040953A (ko) 2023-03-23
RS67943B1 (sr) 2026-04-30
PE20231103A1 (es) 2023-07-19
PL4151277T3 (pl) 2026-05-25
EP4151277A1 (en) 2023-03-22
EP4151277A4 (en) 2024-06-26
CN119258067A (zh) 2025-01-07
AR122973A1 (es) 2022-10-19
CA3187835A1 (en) 2022-01-20
TW202542144A (zh) 2025-11-01
US20220017517A1 (en) 2022-01-20
CN119235864A (zh) 2025-01-03
PT4151277T (pt) 2026-04-06

Similar Documents

Publication Publication Date Title
CN306393788S (zh) 景观路灯(青花瓷)
CN306342691S (zh) 益智玩具蛋盒
BR112023007506B1 (pt) Composição de polietileno, processo para a produção de uma composição de polietileno, artigo, tubo e uso de uma composição de polietileno
CN306247259S (zh) 酒瓶(五指瓶)
CN306038120S (zh) 智能门锁(ny1)
CN305545403S (zh) 过家家玩具
CN305594362S (zh) 指拨式转把电子油门
CN305545130S (zh) 智能自走售卖机
CN305541842S (zh) 电磁炉(816)
CN305564025S (zh) 椅子(轮胎)
CN305554443S (zh) 桌面净化器
CN305551566S (zh) 花缸(波浪口女孩造型)
CN305560101S (zh) 按钮开关
CN305561285S (zh) 标签
CN305536801S (zh) 游戏键盘鼠标转换器
CN305535832S (zh) 垃圾桶(zl-001)
CN305555879S (zh) 电子烟(n16)
CN305527277S (zh) 首饰盒(05)
CN305534749S (zh) 锅煲(福猫)
CN305545277S (zh) 玩具(元素积木土)
CN305546635S (zh) 壁灯(aw9012)
CN305531203S (zh) 锁架
CN305541980S (zh) 生物过滤器
CN305555464S (zh) 台灯
CN305562144S (zh) 艾灸床(多功能百穴艾灸床)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221026

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221026

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20221026

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221028

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20221115

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20221205

R150 Certificate of patent or registration of utility model

Ref document number: 7190612

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250